Gainesville, Florida-based Exactech, Inc. has acquired San Francisco, California-based Muvr Labs Inc., adding to its Active Intelligence® technology platform.
Founded in 2015, Muvr is a “pioneer in intelligent patient wearables and digital communication tools.” Utilizing the Muvr platform, surgeons can remotely monitor joint replacement patient recovery and lessen their workload while “collecting pain scores, exercise adherence, mobility metrics and survey information.”
Exactech develops and produces orthopedic implant devices and surgical instruments. Its Active Intelligence technology platform includes digital communication tools, software and planning applications, and personalized technologies. Exactech has products for the shoulder, knee, hip, foot, and ankle, as well as infection-related solutions and biologics.
Exactech Chief Executive Officer Darin Johnson told OTW, “A key element of our Active Intelligence platform is to help surgeons engage with patients throughout the journey of care. The Muvr platform is a uniquely differentiated solution that delivers on our strategy.”
Johnson continued, “The wearable technology with real-time data delivery and a self-calibrating design making it user-friendly for both the surgeon and the patient. We look forward to continuing the evolution of and expanding access to these smart solutions.”
The Muvr platform includes wearable devices, mobile applications, and chatbot texting. Through its dashboard, surgeons can identify at-risk patients and then connect with them remotely for follow-up.
The “patent-protected, self-calibrating design” of the patient worn wireless sensors “allows the patient to manage the wearable independently.” It also provides the healthcare team “real-time data on each patient’s experience and recovery.”
Orthopedic surgeon Alexander Sah, M.D. remarked that the technology has enabled his patients to “take more ownership of their recovery.” Dr. Sah said, “We have already observed an increase in exercise time, patient satisfaction and a reduction in office calls. It’s also very simple to use because it doesn’t require in-office calibration, which allows patients to use the sensors, at home, unsupervised.”
Surgeons can expect the pilot launch of the Muvr technology in the first part of 2021. The full release is expected by the end of 2021.
